London · Delayed Price · Currency is GBP · Price in CHF PolyPeptide Group AG Company Description
PolyPeptide Group AG operate as a contract development and manufacturing company worldwide.
It focuses on proprietary and generic GMP-grade peptides used by pharmaceutical and biotech companies in approved pharmaceutical products, drugs in clinical development, and in generic products.
It engages in manufacturing custom research grade peptides; and developing neoantigen peptide to support personalized cancer therapies.
The company is also involved in manufacturing peptides for commercially approved peptide therapeutics.
In addition, it manufactures peptide-based generics for human and veterinary markets; and cosmetic peptides.
Further, the company offers regulatory affair support services. The company was founded in 1952 and is headquartered in Zug, Switzerland.
PolyPeptide Group AG is a subsidiary of Draupnir Holding B.V.
| Country | United Kingdom |
| Founded | 1952 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 1,362 |
| CEO | Juan Gonzalez |
Contact Details
Address: Neuhofstrasse 24 Baar Switzerland | |
| Phone | 41 435 020 580 |
Stock Details
| Ticker Symbol | 0AAJ |
| Exchange | London Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | EUR |
| ISIN Number | CH1110760852 |
| SIC Code | 8731 |
Key Executives
| Name | Position |
|---|---|
| Juan Jose Gonzalez | Chief Executive Officer |
| Marc Augustin | Chief Financial Officer |
| Rene Vestergaard | Director of Corporate Finance |
| Olivier Ludemann-Hombourger | Director of Global Innovation and Technology |
| Michael Staheli | Head of Investor Relations and Corporate Communications |
| Christina Del Vecchio | Chief Legal Officer and Corporate Secretary |
| Andreas Liese | Corporate Compliance Manager |
| Trishul Shah MS | Interim Director Global Sales and Marketing |
| Monika Casanova | Chief Human Resources Officer |
| Christophe Chevalier | Head of Technical Department - Braine |